Stay informed with the latest updates for the inheritable blood disorders community. Industry Sanofi Provides Fitusiran Trial Updates at ISTHJul 25, 2022 Industry Prophylactic Therapy for Glanzmann Thrombasthenia Moves Towards…Jul 22, 2022 Industry Sanofi and Sobi® Report Progress with BIVV001 at International Congress Jul 20, 2022 Industry Bayer Announces Discontinuation of Kogenate® FSJun 2, 2022 Industry FDA Grants Breakthrough Status to BIVV001 Jun 1, 2022 Industry FDA Accepts Priority Review BLA for Hemophilia B Gene TherapyMay 24, 2022 Industry First Patient Dosed in Freeline’s Dose-Confirmation Trial for…Mar 25, 2022 Industry BioMarin Provides Update Including Next Steps for Investigational Gene…Jan 11, 2022 Industry Sigilon Announces a Priority Shift in Light of Clinical Trial SetbacksDec 17, 2021 Industry uniQure and CSL Behring Announce Trial Updates for Hemophilia B Gene…Dec 9, 2021 Industry Sigilon Reports Trial Updates for Investigational Hemophilia A Therapy Nov 29, 2021 Industry Spark Announces Multiyear Data Update for Investigational Gene TherapyNov 19, 2021 NBDF & Community NHF Applauds Implementation of the Hemophilia SNF Access ActOct 1, 2021 Medical Prophylaxis Indication Restored for BeneFIX® Sep 14, 2021 Industry Spark Provides Trial Updates for Investigational Gene Therapy SPK-8011Aug 2, 2021 Pagination First page Previous page Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page